U.S. Markets closed

New shareholder challenge to Gilead: What are you doing with billions in tax savings?

Ron Leuty
New shareholder challenge to Gilead: What are you doing with billions in tax savings?

An activist investor wants to know what drug giant Gilead is doing with its multibillion-dollar windfall from the 2017 federal tax overhaul.